Command Palette
Search for a command to run...
SIK3 links synaptic strength to sleep pressure through RhoA signaling
Kitazono, T.; Juichi, M.; Nishida, K.; Nomura, S.; Shimizu, C.; Kato, A.; Iino, Y.; Higashide, N.; Miyanishi, K.; Nakata, S.; Ageta-Ishihara, N.; Sawada, T.; Shi, S.; Funato, H.; Yanagisawa, M.
SIK3 enlarges dendritic spine size and raises non-REM sleep EEG delta density through two opposing RhoA-dependent pathways. Chemical long-term potentiation reduced RhoA activity in an SIK3-dependent manner, while SIK3 phosphorylation activates the RhoA regulator GEF-H1, and the authors report these as clashing SIK3 to RhoA pathways coupling synaptic regulation to sleep homeostasis.
Mild contradiction
1 prior failureOne documented clinical failure (Phase 1 or 2) overlaps with the claimed mechanism.
Abstract excerpt
Sleep is regulated by homeostatic sleep pressure, which accumulates during wakefulness, triggering sleep, and dissipates during sleep, leading to wakefulness. Although recent evidence suggests that synaptic potentiation encodes sleep pressure, the intracellular mechanisms linking synaptic strength to sleep pressure remain unclear. Here we demonstrate that the sleep-promoting kinase SIK3 links synaptic strength and sleep pressure through RhoA signalling. We found that SIK3 is required for dendritic spine enlargement induced by chemical long-term potentiation (cLTP) in cultured cortical pyramidal neurons and positively regulates spine size in the prefrontal cortex in vivo. cLTP reduced RhoA activity in an SIK3-dependent manner during spine enlargement, whereas activation of RhoA reduced EEG delta density in vivo during non-rapid eye movement sleep (NREMS), an indicator of sleep pressure. SIK3 substrate screening identified several RhoA regulators including GEF-H1, and further biochemical analyses found that phosphorylation by SIK3 activates GEF-H1. However, contrary to our expectation, RhoA facilitation through pharmacological activation of GEF-H1 enlarged spine size in cultured neurons, and expression of constitutively active GEF-H1 increased NREMS delta density in a RhoA-dependent fashion. Together, these results indicate that SIK3 enlarges spine size and enhances NREMS delta density through two RhoA-dependent pathways, driving mutually opposing intermediate phenotypes. Our findings identify two clashing SIK3-RhoA signalling pathways that couple synaptic regulation to sleep homeostasis.
Matching Claidex post-mortems
1 of 1 indexedThis is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.

